BioLine RX Ltd ADR buy Quitte
Start price
17.05.18
/
50%
€182.03
Target price
05.06.18
€270.00
Performance (%)
-3.21%
End price
05.06.18
€176.18
Summary
This prediction ended on 05.06.18 with a price of €176.18. With a performance of -3.21%, the BUY prediction for BioLine RX Ltd ADR by Quitte closed slightly in the red. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | 16.794% | 16.794% | -47.603% | -71.875% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by Quitte for this prediction
In the thread BioLine RX Ltd ADR diskutieren
könnte langsam was werden
(Vom Mitglied beendet)